Overcoming Resistance to Drugs Targeting KRAS Mutation
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference105 articles.
1. Clinical relevance of KRAS in human cancers;Jančík;J. Biomed. Biotechnol.,2010
2. Ras oncogenes in human cancer: a review;Bos;Cancer Res.,1989
3. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions;Ostrem;Nature,2013
4. Selective inhibition of oncogenic KRAS output with small molecules targeting the inactive state;Patricelli;Cancer Discov.,2016
5. Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor;Janes;Cell,2018
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biofilm ablation on titanium alloy surface by photothermal and chemotherapeutic synergistic therapy;Journal of Materials Science & Technology;2025-02
2. Identification and Characterization of Novel Small-Molecule Enhancers of the CUL3LZTR1 E3 Ligase KRAS Complex;ACS Chemical Biology;2024-08-28
3. Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer;Lung Cancer;2024-08
4. Resistance to KRAS inhibition in advanced non-small cell lung cancer;Frontiers in Oncology;2024-05-23
5. Emerging Therapies in Kirsten Rat Sarcoma Virus (+) Non-Small-Cell Lung Cancer;Cancers;2024-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3